Concepedia

Author

Keisho Chìn

Japanese Foundation For Cancer ResearchORCID

Also Known As

Chin Keisho, Chin, Keisho, K Chin, K. Chin, K., Chin, K.H. Chin, KEISHO CHIN, Keisho CHIN, Keisho Chin, Keisho Chìn

328

Publications

11K

Citations

40

H-Index

51

Concepts

All Affiliations

Japanese Foundation For Cancer ResearchThe Cancer Institute HospitalNational Cancer Center Hospital EastAichi Cancer CenterShizuoka Cancer Center
KC

About

Keisho Chìn is an author at Japanese Foundation For Cancer Research specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

53

7.2K

2

Health Sciences

10

11

427

3

Cell Biology

3

3

440

4

Allergy

1

1

17

5

Cardiothoracic Surgery

1

1

23

Keisho Chìn

×

98

Publications

10.6K

Citations

40

H-Index

YearCitations

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh,

The Lancet

2017

2.2K

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang,

The Lancet

2018

1.3K

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi,

The Lancet Oncology

2019

1.2K

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

Yasuhide Yamada, Katsuhiko Higuchi, Kazuhiro Nishikawa,

Annals of Oncology

2014

524

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Atsushi Ohtsu, Jaffer A. Ajani, Yu-Xian Bai,

Journal of Clinical Oncology

2013

487

Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus

Atsushi Ohtsu, Narikazu Boku, Kei Muro,

Journal of Clinical Oncology

1999

434

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

Yung‐Jue Bang, Rui‐Hua Xu, Keisho Chìn,

The Lancet Oncology

2017

286

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer

Kei Muro, Tsuyoshi Hamaguchi, Atsushi Ohtsu,

Annals of Oncology

2004

266

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer

Ken Kato, Keisho Chìn, Takaki Yoshikawa,

Investigational New Drugs

2011

234

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Li‐Tzong Chen, Taroh Satoh, Min‐Hee Ryu,

Gastric Cancer

2019

223

Page 1